KHAWLA AMAWI: Open Payments
NPI 1942690748 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 37 payments from 10 companies in 2025. Trend: 2023 $345 · 2024 $524 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $187 |
| Madrigal Pharmaceuticals | 8 | $148 |
| ABBVIE INC. | 6 | $128 |
| GENZYME CORPORATION | 4 | $83 |
| Celltrion USA Inc. | 1 | $38 |
| Medtronic, Inc. | 1 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, RINVOQ, LINZESS, VEGZELMA, INTERSTIM, ZENPEP.
Industry payments across FL — which companies pay providers there.
